These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7851483)

  • 1. Suramin interferes with auto/paracrine insulin-like growth factor I-controlled proliferative loop on human lung cancer cell lines.
    Favoni RE; Ravera F; Pirani P; Ardizzoni A; Noonan D; de Cupis A
    Eur J Pharmacol; 1994 Oct; 264(2):199-206. PubMed ID: 7851483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-insulin-like growth factor-I activity of a novel polysulphonated distamycin A derivative in human lung cancer cell lines.
    de Cupis A; Ciomei M; Pirani P; Ferrera A; Ardizzoni A; Favoni RE
    Br J Pharmacol; 1997 Feb; 120(3):537-43. PubMed ID: 9031761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of insulin-like growth factor I receptors and growth effects in human lung cancer cell lines.
    Rotsch M; Maasberg M; Erbil C; Jaques G; Worsch U; Havemann K
    J Cancer Res Clin Oncol; 1992; 118(7):502-8. PubMed ID: 1320623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
    Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
    J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
    Nakanishi Y; Mulshine JL; Kasprzyk PG; Natale RB; Maneckjee R; Avis I; Treston AM; Gazdar AF; Minna JD; Cuttitta F
    J Clin Invest; 1988 Jul; 82(1):354-9. PubMed ID: 2839551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines.
    Favoni RE; de Cupis A; Ravera F; Cantoni C; Pirani P; Ardizzoni A; Noonan D; Biassoni R
    Int J Cancer; 1994 Mar; 56(6):858-66. PubMed ID: 7509779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells.
    Macaulay VM; Everard MJ; Teale JD; Trott PA; Van Wyk JJ; Smith IE; Millar JL
    Cancer Res; 1990 Apr; 50(8):2511-7. PubMed ID: 2156621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.
    Minniti CP; Maggi M; Helman LJ
    Cancer Res; 1992 Apr; 52(7):1830-5. PubMed ID: 1312901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suramin inhibits the growth of non-small-cell lung cancer cells that express the epidermal growth factor receptor.
    Fujiuchi S; Ohsaki Y; Kikuchi K
    Oncology; 1997; 54(2):134-40. PubMed ID: 9075785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suramin-induced growth inhibition and insulin-like growth factor-I binding blockade in human breast carcinoma cell lines: potentially related events.
    Ravera F; Miglietta L; Pirani P; Ferrini S; Favoni RE
    Eur J Cancer; 1993; 29A(2):225-30. PubMed ID: 8422287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of insulin like growth factor II autocrine growth of Wilms' tumor by suramin in vitro and in vivo.
    Vincent TS; Hazen-Martin DJ; Garvin AJ
    Cancer Lett; 1996 May; 103(1):49-56. PubMed ID: 8616808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of suramin on 125I-insulin-like growth factor-I binding to human meningiomas and on proliferation of meningioma cells.
    Tsutsumi K; Kitagawa N; Niwa M; Himeno A; Taniyama K; Shibata S
    J Neurosurg; 1994 Mar; 80(3):502-9. PubMed ID: 8113863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
    Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suramin blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells.
    Pollak M; Richard M
    J Natl Cancer Inst; 1990 Aug; 82(16):1349-52. PubMed ID: 2166171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy.
    Warshamana-Greene GS; Litz J; Buchdunger E; García-Echeverría C; Hofmann F; Krystal GW
    Clin Cancer Res; 2005 Feb; 11(4):1563-71. PubMed ID: 15746061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-I and human lung fibroblast-derived insulin-like growth factor-I stimulate the proliferation of human lung carcinoma cells in vitro.
    Ankrapp DP; Bevan DR
    Cancer Res; 1993 Jul; 53(14):3399-404. PubMed ID: 8391925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
    Kim YH; Sumiyoshi S; Hashimoto S; Masago K; Togashi Y; Sakamori Y; Okuda C; Mio T; Mishima M
    Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of growth stimulation by suramin in non-small-cell lung cancer cell lines.
    Lokshin A; Peng X; Campbell PG; Barsouk A; Levitt ML
    Cancer Chemother Pharmacol; 1999; 43(4):341-7. PubMed ID: 10071987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.